secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001193125-25-131525
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences annual meeting elects directors; auditor ratification approved
--------------------------------------------------------------------------------

- Elected Richard Vincent, Shiv Kapoor, and David Gryska as Class II directors until 2028.
- David Gryska received 2,786,414 votes for and 1,313,237 withheld (32% withheld).
- Ratified KPMG LLP as independent auditor for FY2025 with 5,285,363 votes for, 2,987 against.
- 5,288,388 shares represented out of 6,583,382 outstanding (80.3% quorum).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525131525/0001193125-25-131525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525131525/d908206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-131525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer